According to the sources provided, Vascepa, also known as Vazkepa (icosapent ethyl), is now available in Europe. Amarin, the pharmaceutical company that produces Vascepa, announced the launch of Vazkepa in Europe in November 2020 [3]. However, it is unclear if Vazkepa is available in all European countries. The FiercePharma article reports that Amarin has secured a marketing authorization for Vazkepa in Europe, which allows the company to sell the drug in all 27 member states of the European Union, as well as in Norway, Iceland, and Liechtenstein [2]. However, the Drug Patent Watch website states that Vascepa is not yet approved for use in the European Union [1]. Therefore, it is possible that Vazkepa is not yet available in all European countries.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.fiercepharma.com/marketing/amarin-launches-vascepa-all-important-europe-as-blockbuster-to-be-heart-drug-slowly
[3] https://amarincorp.com/news-and-media/amarin-announces-first-european-launch-vazkepa-icosapent-ethyl